Attention deficit hyperactivity disorder (ADHD) symptoms and adult ADHD diagnosis in adult men with cannabis dependence

HealthMED

Volumn 6, Issue 6, 2012, Pages 1925-1929

  Aksoy, Umut Mert ^a   Aksoy, Sennur Gunay ^a   Akpinar, Abdullah ^b   Maner, Fulya ^a  

^a University of Health   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adult ADHD; Cannabis dependency; Substance use

Indexed keywords

ARTICLE; ATTENTION DEFICIT DISORDER; CANNABIS ADDICTION; COMORBIDITY; COMPUTER PROGRAM; CONTROLLED STUDY; DETOXIFICATION; DISEASE ASSOCIATION; DSM-IV; HOSPITAL PATIENT; HUMAN; ICD-10; INFORMED CONSENT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM;

EID: 84865520695     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kumar RN, Chambers WA, Pertwee RG. Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia 2001;56:1059-1068.
2. European Monitoring Center for Drugs and Drug Addiction (EMCDDA).(2005). The state of drugs problem in Europe. Annual report (2005).
3. WHO. World Drug Report 2010. New York, NY World Health Organization; 2010.
4. Johns A. 2001 Psychiatric effects of cannabis British Journal Of Psychiatry 2001 178;116-122
5. Morgenstern J, Langenbucher J, Labouvie EW 1994 The generalizability of the dependence syndrome across substances: an examination of some properties of the proposed DSM-IV dependence criteria Addiction. 1994 Sep;89(9): 1105-1113
6. Hall W, Solowij N. 1997 ll Long-term cannabis use and mental health. Br J Psychiatry. 1997 Aug;171:107-108
7. Thomas H. 1996 A community survey of adverse effects of cannabis use Drug and Alcohol Dependence. Vol. 42, no. 3, pp. 201-207. Nov 1996
8. Ögel K, Uǧuz Ş, Sir A, Yenilmez A, Tamar D, Çorapçioǧlu A, Doǧan O, Tot Ş, Bilici M, Tamar D, Evren C, Liman O. Türkiye'de Ilköǧretim ve Ortaöǧretim gençliǧi arasi{dotless}nda esrar kullani{dotless}m yaygi{dotless}nli{dotless}ǧi{dotless}. Baǧi{dotless}mli{dotless}li{dotless}k Dergisi 2003; 4:15-19.
9. Arendt, M., & Munk-Jbrgensen, P. (2004). Cannabis users seeking treatment: Prevalence of psychiatric disorders. Social Psychiatry and Psychiatric Epidemiology, 39, 97-105.
10. The Marihuana Treatment Project Research Group. (2004). Brief treatmentsfor cannabis dependence: Findings from a randomized multisite trial. Journal of Consulting and Clinical Psychology, 72, 455-466.
11. Dennis, M., Godley, S. H., Diamond, G., Tims, F. M., Babor, T., Donaldson, J., et al. (2004). The Cannabis Youth Treatment (CYT study: Main findings from two randomized trials. Journal of Substance Abuse Treatment, 27, 197-213
12. Moore, B. A., & Budney, A. J. (2003). Relapse in outpatient treatment for marijuana dependence. Journal of Substance Abuse Treatment, 25,85-89.
13. Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/ hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003;111(1):179-185.
14. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 2000;157:816-818.
15. Wilens TE Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am 2006;27:283-301.
16. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, Lépine JP, Ormel J, Posada- Villa J, Zaslavsky AM, Jin R. Cross-national prevalence and correlates of adult attention- deficit hyperactivity disorder. Br J Psychiatry 2007:402-409.
17. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-723.
18. Katusic SK, Barbaresi WJ, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol 2005;15(5):764-776.
19. Schubiner H, Tzelepis A, Isaacson JH, Warbasse LH 3rd, Zacharek M, Musial J. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review. J Clin Psychiatry 1995;56(4):146-150.
20. Günay Ş, Savran C, Aksoy UM, Maner F, Turgay A, Yargiç I. Erişkin Dikkat Eksikliǧi Hiperaktivite Ölçeǧinin (Adult ADD/ADHD DSM IV- Based Diagnostic Screening and Rating Scale) Dilsel Eşdeǧerlilik, Geçerlik Güvenirlik ve Norm Çali{dotless}şmasi{dotless}, Türkiye'de Psikiyatri, 2006; 8(2): 98-107.
21. Arnsten A. Catecholamine influences on dorsolateral prefrontal cortical Networks Biol Psychiatry. 2011 Jun 15;69(12):e89-99. Epub 2011 Apr 13
22. Carrol KM, Rounsaville BJ. History and significance of childhood ADHD in treatment seeking cocaine abusers. Compr Psychiatry 1993;34:75-82.
23. Pierce RC, Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse. Neurosci Biobehav Rev 2006;30:215-238
24. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of Attention-deficit/Hyperactivity reduces risk of substance use disorder. Pediatrics 1999;104-120.